期刊
CANCER INVESTIGATION
卷 29, 期 4, 页码 318-324出版社
TAYLOR & FRANCIS INC
DOI: 10.3109/07357907.2011.554477
关键词
MiRNA expression profile; PSA; Positive predictive value; Prostate cancer
类别
资金
- National Cancer Institute [P20 CA118770, U54 CA091431, NCRR/NIH 2G12 RR003048]
Prostate-specific antigen (PSA) test is limited in prostate cancer diagnosis due to its inaccuracy. A new approach which integrates the PSA test with miRNA profiling was investigated to improve prostate cancer diagnosis. Six prostate cancer-related miRNAs (miR-16, -21, -34c, -101, -125b, -141) were tested in five cultured prostate cell lines and 20 human prostate specimens. We found that the miRNA expression profiles were significantly different between nontumorigenic and tumorigenic cell lines and specimens. Positive predictive value analysis of prostate cancer was increased from 40%% to 87.5%% by integrating patient PSA blood levels with miR-21 and miR-141 profiles.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据